Innovative Approach to Oral Health in Sjögren's Syndrome: New Study on Antibacterial Treatment Starts in May
A new Finnish study will investigate an innovative light-activated antibacterial treatment to improve oral health in patients with Sjögren's syndrome.
Sjögren's syndrome is an autoimmune condition that often leads to dry mouth and increases the risk of dental issues such as cavities and gum disease. A new light-activated antibacterial treatment addresses these oral health challenges by targeting the underlying bacterial causes.
Dry mouth caused by Sjögren's syndrome significantly increases the risk of oral diseases such as tooth decay and gum diseases like periodontitis.1 Antibacterial Lumoral therapy represents an innovative approach to reducing these risks.2 For the first time, the effectiveness of the treatment is being explored in Sjögren's syndrome patients. The study will be conducted by oral hygiene students from Metropolia University of Applied Sciences as part of a thesis project...
Click Here to Read More
Sjögren's syndrome is an autoimmune condition that often leads to dry mouth and increases the risk of dental issues such as cavities and gum disease. A new light-activated antibacterial treatment addresses these oral health challenges by targeting the underlying bacterial causes.
Dry mouth caused by Sjögren's syndrome significantly increases the risk of oral diseases such as tooth decay and gum diseases like periodontitis.1 Antibacterial Lumoral therapy represents an innovative approach to reducing these risks.2 For the first time, the effectiveness of the treatment is being explored in Sjögren's syndrome patients. The study will be conducted by oral hygiene students from Metropolia University of Applied Sciences as part of a thesis project...
Click Here to Read More